Darers & Doers Podcast: The Quest for AI-Powered Cancer Vaccines
Apr.09.2026
Likang Life Sciences founder Chen Li explains how his Beijing startup is developing personalized mRNA cancer vaccines and why China’s biotech rise matters globally
Cancer treatment has long relied on a largely fixed set of options: surgery, radiation, chemotherapy and targeted drugs. But a new generation of biotech founders is trying to push the field toward something more precise — treatments built around the biology of a single patient.
In this debut episode of Darers & Doers, a special segment of the China Business Uncovered podcast, Likang Life Sciences Founder and CEO Chen Li explains how his Beijing-based biotech startup is using artificial intelligence to develop personalized mRNA cancer vaccines.
MORE WAYS TO LISTEN
- 1Analysis: China’s Local Fiscal Recovery Hides Scramble to Plug Budget Holes
- 2Analysis: Why China Chip Stocks Are Sliding After Sharp Rally
- 3Mainland Investors Scramble for Hong Kong Accounts as Offshore Trading Curbs Bite
- 4Exclusive: China Halts Data-Backed Securities to Curb Local Debt Arbitrage
- 5China’s Big-Rig Makers Race to Hong Kong as Investors Bet on Freight Electrification
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas




